Soleno Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.975; its P/E ratio is -14.61; Soleno Therapeutics is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -8.82M	$ -7.85M	$ -8.36M	$ -5.49M	$ -6.10M
EBITDA	$ -8.33M	-	$ -7.87M	$ -5.00M	$ -5.61M
Net Income Common Stockholders	$ -8.82M	$ -8.47M	$ -8.36M	$ -5.49M	$ -6.13M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 52.44M	$ 19.37M	$ 7.87M	$ 14.60M	$ 19.75M
Total Assets	$ 63.55M	$ 30.94M	$ 19.51M	$ 26.50M	$ 31.98M
Total Debt	$ 470.00K	$ 485.00K	$ 39.00K	$ 155.00K	$ 239.00K
Net Debt	$ -51.97M	$ -18.88M	$ -7.83M	$ -14.45M	$ -19.51M
Total Liabilities	$ 40.33M	$ 18.52M	$ 16.89M	$ 16.15M	$ 16.78M
Stockholders Equity	$ 23.22M	$ 12.43M	$ 2.64M	$ 10.35M	$ 15.20M
Cash Flow	-
Free Cash Flow	$ -6.30M	-	$ -6.73M	$ -5.21M	$ -4.66M
Operating Cash Flow	$ -6.30M	-	$ -6.73M	$ -5.20M	$ -4.66M
Investing Cash Flow	-	-	-	$ -6.00K	$ 0.00
Financing Cash Flow	$ 39.40M	-	-	-	$ 342.00K

Currency in USD

Soleno Therapeutics Earnings and Revenue History

Income Statement >

Soleno Therapeutics Debt to Assets

Balance Sheet >

Soleno Therapeutics Cash Flow

Cash Flow >

Soleno Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing